Nasdaq Minimum Bid Price Rule

Clearmind Medicine Inc. (NASDAQ: CMND) is set to conduct a 1-for-30 reverse share split of its issued and outstanding ordinary shares, no par value, effective starting Nov. 28, 2023.  See Also: Psychedelics Capital Moves: Beckley Waves Raises $3.3M, Clearmind's $2.25M Public Offering...